Clinical Trials Sponsored by Hassane M. Zarour, MD

Total 3 results

Hassane M. Zarour, MD
National Cancer Institute (NCI)

Completed

CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors

NY-ESO-1-expressing Tumors

United States
Hassane M. Zarour, MD
Merck Sharp & Dohme LLC; Melanoma Research Alliance

Completed

Treatment of Advanced Melanoma With MK-3475 and Peginterferon

Melanoma

United States
Zarour, Hassane, MD
Merck Sharp & Dohme LLC

Active, not recruiting

Fecal Microbiota Transplant (FMT) in Melanoma Patients

Melanoma

United States

3

Subscribe